RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)
Clinical trial NCT04597125 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04597125
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-09
- Primary completion
- 2025-11-21
- Enrollment
- 654
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.